- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Bioharvest Sciences Inc (BHST)
Bioharvest Sciences Inc stock price live, this page displays NASDAQ BHST stock exchange data. View the BHST premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Bioharvest Sciences Inc real time stock price chart below.
What Is the Bioharvest Sciences Inc Stock Price Today?
The Bioharvest Sciences Inc stock price today is 1.8500.
What Is the Stock Symbol for Bioharvest Sciences Inc?
The stock symbol for Bioharvest Sciences Inc is "BHST."
What Stock Exchange Does Bioharvest Sciences Inc Trade On?
Bioharvest Sciences Inc is listed and trades on the NASDAQ stock exchange.
Is Bioharvest Sciences Inc a Good Stock to Buy?
Determining whether Bioharvest Sciences Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BHST quote. (ISIN: CA09076J2074)
What Is the Bioharvest Sciences Inc Stock Price Today?
The Bioharvest Sciences Inc stock price today is 1.8500.
What Is the Stock Symbol for Bioharvest Sciences Inc?
The stock symbol for Bioharvest Sciences Inc is "BHST."
What Stock Exchange Does Bioharvest Sciences Inc Trade On?
Bioharvest Sciences Inc is listed and trades on the NASDAQ stock exchange.
Is Bioharvest Sciences Inc a Good Stock to Buy?
Determining whether Bioharvest Sciences Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BHST quote. (ISIN: CA09076J2074)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.8000
1.9000
52 wk Range
1.8000
12.8000
Trading near 52-week Low
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.80001.9000
52 wk Range
1.800012.8000
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
BHST Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
10.5000
Upside
+467.57%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Impressive gross profit margins
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Strong Sell
Analyst Ratings
3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 10.5000
(+467.57% Upside)
Bioharvest Sciences Inc Earnings Call Summary for Q2/2026
- BioHarvest narrowed Q2 2026 net loss to $3.7M ($0.17/share) vs. $4.1M ($0.24/share) year-ago; revenue rose 3.8% to $8.8M with 58% gross margin.
- Company announced first major CDMO fragrance manufacturing deal projected to generate $20M-$30M revenue in 2027-2028; reaffirmed path to EBITDA breakeven in 2027.
- Full-year 2026 revenue guidance cut to $37M-$40M from $42M-$48M, reflecting strategic shift toward higher-value CDMO projects over volume growth.
- Cash position strengthened to $16.2M from $3.7M year-ago; management committed to avoiding equity raises while scaling production capacity for new contracts.
- VINIA segment guidance lowered to $33M-$35M revenue with EBITDA shifting to $1.5M-$2.5M loss as company reduces marketing spend to fund manufacturing expansion.
Last Updated: 2026-08-11, 08:54 a/m
Read Full TranscriptEarnings
Latest Release
Aug 11, 2026
EPS / Forecast
-0.16 / --
Revenue / Forecast
8.84M / --
Compare BHST to Peers and Sector
Metrics to compare | BHST | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBHSTPeersSector | |
|---|---|---|---|---|
P/E Ratio | −3.8x | −2.7x | 11.3x | |
PEG Ratio | −0.16 | 0.02 | 0.03 | |
Price/Book | 2.1x | 0.9x | 1.5x | |
Price / LTM Sales | 1.2x | 1.9x | 0.9x | |
Upside (Analyst Target) | - | 41.7% | 25.6% | |
Fair Value Upside | Unlock | 18.6% | 13.6% | Unlock |
BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through two segments: Products and CDMO Services. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, marketing, and sale of science-based health and wellness nutraceutical solutions that are manufactured and sold as dietary supplements and functional food and beverages, as well as the manufacturing, marketing, and sale of science-based health, pharmaceutical, and cosmeceutical solutions. The company also provides contract development and manufacturing operation services. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red wine. The company has a strategic collaboration with Tate & Lyle plc for the development of plant-based sweetener molecules. The company is based in Vancouver, Canada.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Bioharvest Sciences (BHST) Stock Price Today?
The Bioharvest Sciences stock price today is 1.8500 USD.
What Stock Exchange Does Bioharvest Sciences Trade On?
Bioharvest Sciences is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Bioharvest Sciences?
The stock symbol for Bioharvest Sciences is "BHST."
What Is the Bioharvest Sciences Market Cap?
As of today, Bioharvest Sciences market cap is 42.3900M USD.
What Is Bioharvest Sciences's Earnings Per Share (TTM)?
The Bioharvest Sciences EPS (TTM) is -0.5253.
From a Technical Analysis Perspective, Is BHST a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Bioharvest Sciences Stock Split?
Bioharvest Sciences has split 1 times.
How Many Employees Does Bioharvest Sciences Have?
Bioharvest Sciences has 89 employees.
What is the current trading status of Bioharvest Sciences (BHST)?
As of Sep 12, 2026, Bioharvest Sciences (BHST) is trading at a price of 1.8500 USD, with a previous close of 1.8700 USD. The stock has fluctuated within a day range of 1.8000 USD to 1.9000 USD, while its 52-week range spans from 1.8000 USD to 12.8000 USD.
What Is Bioharvest Sciences (BHST) Price Target According to Analysts?
The average 12-month price target for Bioharvest Sciences is 10.5000 USD, with a high estimate of 15 USD and a low estimate of 5 USD. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +467.57% Upside potential.
What Is the BHST Premarket Price?
BHST's last pre-market stock price is 1.9400 USD. The pre-market share volume is 20.0000, and the stock has decreased by 0.0700, or 3.7400%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.